Context Therapeutics Inc

NASDAQ:CNTX   11:07:10 AM EDT
2.05
-0.03 (-1.44%)
Earnings Announcements

Context Therapeutics Reports Full Year 2021 Financial Results

Published: 03/23/2022 20:29 GMT
Context Therapeutics Inc (CNTX) - Context Therapeutics® Reports Full Year 2021 Operating and Financial Results.
Context Therapeutics - Expects That Its Cash and Cash Equivalents Will Be Sufficient to Fund Its Operations Into 2024.
Revenue is expected to be $0 Million
Adjusted EPS is expected to be -$0.25

Next Quarter Revenue Guidance is expected to be $0 Million
Next Quarter EPS Guidance is expected to be -$0.31

More details on our Analysts Page.